Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Burning Rock Biotech Q3 EPS $(0.23) Up From $(0.31) YoY, Sales $17.48M Down From $21.74M YoY

Author: Benzinga Newsdesk | November 30, 2023 02:29am
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.23) per share. This is a 25.81 percent increase over losses of $(0.31) per share from the same period last year. The company reported $17.48 million in sales this quarter. This is a 19.56 percent decrease over sales of $21.74 million the same period last year.

Posted In: BNR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist